National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
复制标题
DOI：
10.1016/j.jaad.2020.09.001
复制
发表时间：
2020-12-01
影响因子：
13.8
通讯作者：
Ritchlin, Christopher T.
中科院分区：
文献类型：
--
作者：
Gelfand, Joel M.;Armstrong, April W.;Ritchlin, Christopher T.
目的：为在2019冠状病毒病（COVID-19）大流行期间提供银屑病疾病管理指导。研究设计：召集了一个由18名具有皮肤病学、风湿病学、流行病学、传染病和重症监护专业知识的医生投票成员组成的工作组（TF）。工作队由无表决权的成员补充，其中包括研究员和国家精神病学基金会工作人员。与银屑病社区相关的临床问题由NPF收到的问题告知。结果：TF批准了22项指导声明。所有发言的平均票数都在同意的范围内。所有建议的指南声明都得到了推荐，9个具有高度共识，13个具有中度共识。局限性：许多指南声明背后的证据质量有限。这些声明为银屑病患者的管理提供了指导，涉及的主题包括疾病及其治疗如何影响COVID-19风险和结果，如何在大流行期间优化医疗护理，患者应该做些什么来降低感染严重急性呼吸系统综合征冠状病毒2的风险，以及如果他们患上COVID-19应该做些什么。该指南旨在成为一份活的文件，将由专题工作队随着数据的出现而更新。
Objective: To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic.Study design: A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clinical questions relevant to the psoriatic disease community were informed by questions received by the NPF. A Delphi process was conducted.Results: The TF approved 22 guidance statements. The average of the votes was within the category of agreement for all statements. All guidance statements proposed were recommended, 9 with high consensus and 13 with moderate consensus.Limitations: The evidence behind many guidance statements is limited in quality.Conclusion: These statements provide guidance for the management of patients with psoriatic disease on topics ranging from how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what they should do if they develop COVID-19. The guidance is intended to be a living document that will be updated by the TF as data emerge.